E-prescribing leads to more, cheaper generic Rx fills

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American



On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Even as some states have required pharmacists to dole out generic drugs when they're available and insurers have offered financial incentives to doctors to prescribe them, the cost of prescription medications has continued to climb. Now there's evidence that docs who prescribe electronically are more likely to select generic than pricey brand-name meds.

Massachusetts physicians who used an e-prescribing system increased their use of generics by 6 percent—from 55 percent to 61 percent of all prescriptions they filled—compared with when they wrote them out by hand the old-fashioned way, according to a study in this week's Archives of Internal Medicine. Doctors who weren’t taught to use software that lets them fill 'scripts wirelessly also increased their use of generics, but by only 3 percent (from about 53 percent to 56 percent). The 18-month study involved more than 35,000 doctors, some 2,000 of whom had the option of using the PocketScript software. (The federal Agency for Healthcare Research and Quality and the U.S. National Institutes of Health paid for the study.)

If the practice were widely adopted, nearly $4 billion per 100,000 patients could be saved annually, the Harvard Medical School authors write.

Though Medicare is offering a 2 percent bonus in 2009 and 2010 to docs who e-prescribe, according to HealthDay News, most physicians haven’t adopted the e-Rx habit. Even in the study, just 20 percent of the prescriptions doled out by docs who had the e-software were filled electronically. The study didn't explore why.

But convenience isn’t the only reason doctors and patients might want to reconsider generics; research published last week showed that generic heart meds work just as well as brand names.

Image by iStockphoto/Christie & Cole Studio, Inc.                     

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe